Course Available: Psychiatric Medications and Long-Term Outcomes for Schizophrenia
with Martin Harrow
In this course, Martin Harrow, Ph.D., from the University of Illinois College of Medicine, presents his findings from his 26-year study of individuals diagnosed with schizophrenia and other psychotic disorders, and the difference in outcomes related to use of antipsychotic medications. His prospective study is arguably the best research that has ever been done on the long-term effects of antipsychotic medications, and it produced results – as Harrow discusses in his presentation – that completely confounded conventional wisdom. Those who stopped taking antipsychotic medications had significantly better global outcomes over the long term. This two-part course includes a one-hour discussion of the study and its implications moderated by Robert Whitaker, with both Dr. Harrow and psychiatrist Thomas Jobe, who collaborated with Harrow on the research.
This course qualifies for 3.0 CMEs, approved by the American Academy of Family Physicians, and 2.5 CEUs, approved by Commonwealth Educational Seminars for psychologists, social workers, licensed marriage and family counselors, nurses and certified addiction counselors.
For more information: